|
Management of Immune Checkpoint Inhibitor-Related Toxicities |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Newer Approaches to Treatment of Bladder Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Team-Based Case Review: Oligometastatic Prostate, Non-Small Cell Lung, and Colorectal Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Smoking Cessation for Patients with Cancer: State of the Evidence |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
The Impact of Frontline Immune Checkpoint Inhibitors on Therapy for Relapsed/Refractory Hodgkin Lymphoma |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to Management of Multiple Myeloma |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Best Practices for Oncology Urgent Care |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Expansion of Recommendations for Hereditary Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates in the Multidisciplinary Approach for Resectable Gastroesophageal Adenocarcinoma and Peritoneal-Limited Disease |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Team-Based Case Review: Hepatocellular Carcinoma |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to the Management of Cervical Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Advances in Treatment of Recurrent Ovarian Cancer and Rare Malignant Germ Cell Tumors |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Advances in Head and Neck Cancers: Nasopharyngeal and Oral Cancers |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to Systemic Therapy for Differentiated Thyroid Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Facebook
Twitter
LinkedIn
Forward